BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11913472)

  • 1. Can metabolic manipulation reverse myocardial dysfunction?
    Cokkinos DV
    Eur Heart J; 2001 Dec; 22(23):2138-9. PubMed ID: 11913472
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial metabolic manipulation: a new therapeutic approach in heart failure?
    O'Meara E; McMurray JJ
    Heart; 2005 Feb; 91(2):131-2. PubMed ID: 15657211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic treatment of myocardial ischaemia.
    Ferrari R
    Eur Heart J; 1999 Aug; 20(16):1144-5. PubMed ID: 10448019
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trimetazidine (Preductal). A new approach in controlling myocardial ischemia].
    Eliseev OM
    Ter Arkh; 1996; 68(8):57-63. PubMed ID: 9019836
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation.
    Stanley WC; Sabbah HN
    Heart Fail Rev; 2005 Dec; 10(4):275-9. PubMed ID: 16583175
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic therapy for heart failure.
    Essop MF; Opie LH
    Eur Heart J; 2004 Oct; 25(20):1765-8. PubMed ID: 15474689
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assessment of Efficacy and Safety of Metabolic Therapy With Trimetazidine MB in Patients With Ischemic Heart Disease and Chronic Heart Failure].
    Gorbunova ML; Vilkova AV
    Kardiologiia; 2016 Mar; 56(3):67-72. PubMed ID: 28294892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic modulation as a target for heart failure treatment: current perspective.
    Chenniapan S; Manchanda SC
    Indian Heart J; 2007; 59(4):370-4. PubMed ID: 19126947
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of trimetazidine for out of hospital physical rehabilitation after myocardial infarction].
    Aronov DM; Tartakovskiĭ LB; Novikova NK; Pisareva NA; Smolenskiĭ VS; Zhidko NI
    Kardiologiia; 2002; 42(11):14-20. PubMed ID: 12494029
    [No Abstract]   [Full Text] [Related]  

  • 10. Trimetazidine in the myocardial cell mechanisms of cytoprotection.
    Labrid C
    Rom J Intern Med; 1998; 36(3-4):137-44. PubMed ID: 10822510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic approach to heart failure - evidence that trimetazidine improves symptoms, left ventricular function and possibly prognosis.
    Jackson G
    Int J Clin Pract; 2006 Aug; 60(8):891-2. PubMed ID: 16893429
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enhancement of antioxidant status of the elderly patients with ischemic heart disease in response to amino acid composition of MP-33 in combined therapy with trimetazidine].
    Kalinina EB; Komissarova IA; Zaslavskaia RM; Zhdanov IuA
    Klin Med (Mosk); 2002; 80(5):50-3. PubMed ID: 12087889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of trimetazidine in management of ischemic cardiomyopathy.
    Bertomeu-Gonzalez V; Bouzas-Mosquera A; Kaski JC
    Am J Cardiol; 2006 Sep; 98(5A):19J-24J. PubMed ID: 16931202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic modulation in heart failure: high time for a definitive clinical trial.
    Ashrafian H; Neubauer S
    Heart; 2011 Feb; 97(4):267-8. PubMed ID: 21258118
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of long-term therapy with trimetazidine in patients with ischemic heart disease in combination with chronic obstructive pulmonary disease].
    Kolomoets NM; Baksheev VI; Zarubina EG; Uvaĭsova IU
    Kardiologiia; 2008; 48(2):47-51. PubMed ID: 18261009
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic therapy for the diabetic patients with ischaemic heart disease.
    Rosano GM; Vitale C; Volterrani M; Fini M
    Coron Artery Dis; 2005 Nov; 16 Suppl 1():S17-21. PubMed ID: 16340399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trimetazidine in correction of chronic heart failure in patients with ischemic heart disease].
    Nedoshivin AO; Kutuzova AE; Nesterova IV; Mikhaĭlova IE; Rubashkina EI; Novikova NA; Liasnikova EA; Perepech NB
    Kardiologiia; 2002; 42(3):12-5. PubMed ID: 12494179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic approach to myocardial ischemia: a novel therapeutic strategy for patients with coronary artery disease?
    Rizzon P; Iliceto S; Marangelli V
    Cardiologia; 1995 Oct; 40(10):717-20. PubMed ID: 8819732
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of myocardial metabolism: an emerging therapeutic principle.
    Horowitz JD; Chirkov YY; Kennedy JA; Sverdlov AL
    Curr Opin Cardiol; 2010 Jul; 25(4):329-34. PubMed ID: 20535068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure.
    Dalal JJ; Mishra S
    Indian Heart J; 2017; 69(3):393-401. PubMed ID: 28648439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.